The IND clearance enables Trace to initiate first-in-human clinical studies evaluating the safety and intraoperative performance of LGW16-03 in surgical settings...
The JADA System for treatment of abnormal postpartum uterine bleeding, and the team behind the product, join Laborie, strengthening the company's commitment to improving maternal health...
Polarean’s Xenon MRI platform is opening a new window into the pulmonary microvasculature, long considered a “silent zone” in cardiopulmonary disease and reshaping how pharma sponsors evaluate therapeutic response...
Researchers develop an innovative dural patch that achieves rapid, watertight sealing of dural tears, boasting high biocompatibility...
Artificial intelligence simplifies patient workflow, improves image quality, and accelerates exams...
This important regulatory milestone further strengthens Spectrumedics' global expansion strategy...
This initiative reaffirms NTPC’s commitment to inclusive development and its continued focus on strengthening critical healthcare infrastructure through meaningful CSR interventions...
203 patients were randomised to receive either endocrine monotherapy or combination therapy consisting of a doublet (endocrine therapy plus a CDK4/6 inhibitor) ...
In 2025, Tiger BioSciences supported and generated five peer-reviewed retrospective clinical studies, two of which focused on the company's flagship product, completeFT...
From blood bank software and immunohematology analysers, to HIV diagnostics and platelet rich plasma systems, the 2025 approval landscape signals a clear shift towards automation, safety, traceability, and point of care innovation across transfusion and laboratory medicine...
